시장보고서

상품코드

1756448

세계의 CRISPR 기반 진단 시장 : 제품별, 기술별, 용도별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

CRISPR-Based Diagnostics Market, By Product, By Technology, By Application, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2025년 05월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 269 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

CRISPR 기반 진단 시장 규모는 2024년 31억 233만 달러로 2025년부터 2032년까지 CAGR 16.93%로 확대될 전망입니다.

CRISPR 기반 진단 시장 역학

CRISPR 기반 진단 시장은 전 세계 감염성 질환의 증가에 의해 주도되고 있습니다. 감염성 질환으로 인한 사망자 수는 연간 1,000만 명 이상으로 추정되며(WHO 기준), 신속하고 정확한 진단 도구가 필요합니다. 또한, 전 세계적으로 유전성 질환과 암 발생률이 증가함에 따라 조기 발견과 맞춤형 의료를 위한 정확한 진단 접근법의 필요성이 높아지고 있습니다. 미국 국립보건원(NIH)에 따르면, 유전성 질환은 전 세계적으로 수백만 명의 사망자를 발생시키고 있으며, 암은 주요 사망 원인으로, CRISPR 진단법은 특정 유전자 변이 및 암 바이오마커를 높은 특이성으로 검출할 수 있는 잠재력을 가지고 있습니다. 자원이 부족한 환경에서 신속한 검사 결과와 분산된 검사의 필요성으로 인해 현장진단(POC)에 대한 수요가 증가하고 있으며, CRISPR 기반 분석법은 사용하기 쉬운 POC 장비로 개선될 수 있으며, 전염병 발생 지역이나 발병 시 진단에 변화를 가져올 수 있습니다. 변화를 가져올 수 있습니다.

특이성과 활성이 향상된 새로운 CAS 효소의 식별, 분석 설계 및 신호 증폭 방법의 발전 등 CRISPR 시스템의 기술 발전은 CRISPR 기반 진단의 능력과 범위를 점진적으로 향상시킬 것입니다. 감염 및 유전성 질환에서 암에 이르기까지 다양한 질병 범주에 걸친 광범위한 응용 분야는 거대한 잠재적 시장을 제시합니다. 단일 반응에서 여러 표적을 동시에 검출하는 멀티플렉스 분석법을 제작할 수 있는 능력은 경제성과 효율성 측면에서 큰 이점을 제공합니다. 또한, CRISPR 진단법과 미세유체공학 및 기타 첨단 기술과의 융합은 매우 민감하고 자동화된 진단 플랫폼을 만들 수 있습니다. 유전체학 및 진단학 분야의 연구개발에 대한 지출 증가는 정부 및 민간 부문의 자금 지원을 포함하여 시장 확대와 기술 혁신의 원동력이 되고 있습니다. 그러나 인허가 장벽과 표준화의 필요성은 이러한 신기술의 보편적 보급을 가로막는 장애물이 되고 있습니다.

CRISPR 기반 진단 시장 : 주요 인사이트

CRISPR 기반 진단 분석에는 소모품이 지속적으로 필요하기 때문에 시약 및 키트 부문이 가장 큰 비중을 차지합니다. 더 많은 연구와 진단 테스트는 가이드 RNA, Cas 효소 및 기타 시약이 필요한 키트에 대한 지속적인 수요로 이어질 것입니다.

Cas9는 CRISPR 기반 진단에서 가장 많이 조사되고 가장 널리 사용되는 Cas 효소이며, 그 이유는 메커니즘이 잘 알려져 있고, 도구와 자원이 풍부하며, 다재다능하기 때문입니다.

병원과 진단 검사실은 CRISPR 기반 진단의 가장 큰 수요처입니다. 그 이유는 기존 인프라, 높은 처리량 검사 능력, 무수히 많은 질병을 검출하기 위한 최첨단 분자진단법의 활용이 증가하고 있기 때문입니다.

제약회사 및 생명공학 기업들은 의약품 개발, 임상시험, 품질 관리를 위해 CRISPR 기반 진단을 점점 더 많이 활용하고 있습니다.

북미가 CRISPR 기반 진단 시장에서 가장 큰 점유율을 차지하고 있습니다. 이는 북미에 저명한 연구 시설, 저명한 생명공학 및 제약 조직이 많이 존재하고 진단 및 유전체학 연구에 많은 정부 자금이 투입되고 있기 때문입니다.

CRISPR 기반 진단 시장 : 세분화 분석

세계 CRISPR 기반 진단 시장은 제품, 기술, 용도, 최종 용도, 지역에 따라 세분화됩니다.

기술별로 시장은 Cas9, Cas12, 기타로 구분되며, Cas9 부문이 가장 큰 시장 점유율을 차지하고 있습니다. 이는 Cas9이 가장 광범위하게 연구되고 가장 잘 이해된 CRISPR 관련 효소이기 때문입니다. 강력하고 다양한 DNA 표적화 능력으로 인해 시장 초기에 개발된 수많은 진단 애플리케이션의 주축이 되었으며, Cas9 기반 도구, 시약 및 표준화된 프로토콜의 대규모 컬렉션을 사용할 수 있기 때문에 연구 및 진단 개발에 광범위하게 적용될 수 있습니다. 연구 및 진단 개발에 광범위하게 적용될 수 있습니다. 또한, Cas9 기반 진단 테스트의 조기 달성 및 확립은 그 지배적인 역할을 재확인했으며, Cas12 구성요소는 시장에서 가장 빠르게 개발되고 있습니다. 이는 crRNA 어레이를 소화하는 능력과 독특한 ssDNA 트랜스 절단 활성과 같은 Cas12 효소가 제공하는 특별한 강점에 의해 주도되고 있습니다. 이 후자의 능력은 Cas9 기반 접근법보다 더 높은 민감도와 쉬운 분석 설계를 제공할 수 있습니다. 더 나은 특성을 가진 새로운 Cas12 변이체의 지속적인 식별과 현장 진단에 대한 잠재적 응용에 대한 연구의 증가가 빠른 성장률을 주도하고 있습니다.

응용 프로그램에 따라 시장은 감염성 질환 진단, 유전자 질환 진단, 암 진단, 기타로 분류됩니다. 감염성 질환 진단 시장은 가장 큰 점유율을 차지하고 있습니다. CRISPR 기반 진단은 최근 유행병에서 볼 수 있듯이 신종 및 신흥 감염성 병원체 검출에 빠르게 재사용할 수 있기 때문에 감염병 확산 방지 및 환자 치료 강화에 중요한 역할을 하고 있습니다. 현장 진단의 가능성과 미량의 바이러스와 박테리아를 감지하는 높은 민감도 또한 이 분야를 지배하는 요인입니다. 암 진단약은 시장에서 가장 빠르게 성장하고 있는 분야입니다. 그 배경에는 전 세계 암 발병률의 증가와 환자의 예후를 개선하기 위한 보다 빠르고 정확한 진단 도구의 필요성이 있습니다. 민감도와 특이성이 뛰어난 CRISPR 기술은 액체 생검에서 순환 종양 DNA(ctDNA)와 같은 암 특이적 바이오마커의 검출에 큰 잠재력을 가지고 있습니다. 이를 통해 암의 조기 발견, 치료 효과 모니터링, 맞춤형 암 치료에 혁명을 일으킬 수 있습니다.

CRISPR 기반 진단 시장 : 지역별 분석

북미가 가장 큰 시장 점유율을 차지하고 있습니다. 이 지역의 강력한 연구 기반, CRISPR 기술 발전에 적극적으로 기여하고 있는 많은 대형 생명공학 기업 및 제약사, 유전체 및 진단 연구에 대한 막대한 정부 지원이 이 지역의 우위의 배경입니다. 또한, 북미의 강력한 헬스케어 인프라와 첨단 분자진단법의 높은 보급률도 추가적인 요인으로 작용하고 있습니다. 이 지역 시장의 주요 국가는 첨단 연구 및 상업화의 중심지인 미국과 생명공학 및 헬스케어 혁신에 중점을 두고 있는 캐나다입니다. 아시아태평양은 CRISPR 기반 진단 의약품의 시장 개척이 가장 빠르게 진행될 것으로 예상됩니다. 이러한 성장은 이 지역 인구의 감염성 및 유전성 질환 발생률 증가, 의료비 지출 증가, 첨단 진단 기술에 대한 인식과 수용성 증가, 중국, 인도, 한국 등의 국가에서 연구개발에 대한 투자 증가 등 다양한 요인에 기인하고 있습니다.

CRISPR 기반 진단 시장 : 경쟁 구도

CRISPR 기반 진단 시장은 기존 생명과학 기업, 집중적인 진단 개발 기업, 최첨단 스타트업이 혼재되어 있으며, 빠르게 진화하는 경쟁 환경이 특징입니다. 주요 기업들은 진단에서 CRISPR 기술의 유용성 확대, 분석 민감도 및 특이성 향상, 편리하고 현장 진료에 기반한 솔루션 창출을 목표로 지속적인 연구개발을 진행하고 있습니다. 전략적 제휴, 파트너십, 라이선싱은 일반적으로 상호 보완적인 역량을 활용하여 제품 개발 및 상용화를 촉진하기 위해 이루어지고 있습니다. 새로운 CRISPR-Cas 시스템과 새로운 분석 포맷의 지속적인 발굴은 경쟁 압력을 더욱 증가시키고 있습니다. 기업들은 제품 혁신, 기술 혁신, 공동 연구, 규제 경로의 지능적 탐색을 기반으로 차별화를 추구하고 있습니다. 감염성 질환, 암, 유전성 질환 등 다양한 용도를 위한 적극적이고 신뢰할 수 있으며 확장 가능한 CRISPR 기반 진단 플랫폼의 개발은 이 새로운 경쟁 환경에서 중요한 모티브가 되고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 : CRISPR 기반 진단 업계

경쟁 대시보드
- 경쟁 벤치마크
- 경쟁 포지셔닝
기업 개요
- Thermo Fisher Scientific Inc.
- Integrated DNA Technologies, Inc.
- Molbio Diagnostics
- Horizon Discovery
- Synthego Corporation
- Mammoth Biosciences
- Sherlock Biosciences
- Caribou Biosciences
- CrisprBits
- ToolGen Inc.

제13장 AnalystView의 전방위적 분석

ksm 25.07.03

REPORT HIGHLIGHT

CRISPR-Based Diagnostics Market size was valued at US$ 3,102.33 Million in 2024, expanding at a CAGR of 16.93% from 2025 to 2032.

CRISPR diagnostics are a ground breaking category of molecular diagnostic technologies that utilize the accuracy and programmability of the clustered, regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (CAS) protein systems. These new technologies are novel alternatives and supplements to conventional diagnostic approaches, promising the ability to detect a broad range of analytes through rapid, sensitive, specific, and cost-efficient analysis. CRISPR-based diagnostics utilize the programmable RNA-guided DNA or RNA-targeting activity of CAS enzymes. When combined with a guide RNA (gRNA) complementary to a target sequence, these enzymes can be designed to bind specifically to and recognize the target nucleic acid. The diagnostic application combines this highly specific recognition with a signal-generating mechanism. The CRISPR system's intrinsic programmability, via gRNA design, enables the facile development and deployment of diagnostic tests for various targets, from infectious disease pathogens and genetic mutations to cancer biomarkers.

CRISPR-Based Diagnostics Market- Market Dynamics

The market for CRISPR-based diagnostics is driven by the rising global infectious disease burden, with an estimated over 10 million deaths yearly caused by infectious agents (as per WHO), requiring quick and precise diagnostic tools. Moreover, the rising incidence of genetic disorders and cancer globally drives the need for accurate diagnostic approaches for early detection and customized medicine. Genetic disorders have millions of victims worldwide, and cancer is a major cause of death, according to the National Institutes of Health (NIH). CRISPR diagnostics can potentially detect particular genetic mutations and biomarkers of cancer with high specificity. Point-of-care (POC) diagnostics are increasingly in demand due to a need for quick test results in resource-poor settings and decentralized testing. CRISPR-based assays can be modified for user-friendly POC devices, potentially transforming diagnostics in epidemic regions and during outbreaks.

Advances in technology in CRISPR systems, such as identifying new CAS enzymes with increased specificity and activity and advances in assay design and signal amplification methods, progressively enhance the ability and range of CRISPR-based diagnostics. The wide range of applications across different disease categories, from infectious diseases and genetic diseases to cancer, presents an enormous potential market. The capability to generate multiplexed assays to detect multiple targets within a single reaction in parallel is a huge advantage in economics and efficiency. In addition, the convergence of CRISPR diagnostics with microfluidics and other cutting-edge technologies can potentially create very sensitive and automated diagnostic platforms. Increased spending on research and development in genomics and diagnostics, including impressive government and private sector funding, continues to drive market expansion and innovation. However, the approval barriers and the requirement for standardization remain barriers to the universal take-up of these new technologies.

CRISPR-Based Diagnostics Market- Key Insights

Reagent and Kits segment is the largest as there is continuous requirement for consumables in CRISPR-based diagnostic assays. More research and diagnostic tests lead to a consistent demand for kits with guide RNAs, Cas enzymes, and other reagents required.

Cas9 has been the most studied and the most widely used Cas enzyme in CRISPR-based diagnostics as it has a well-characterized mechanism, which is well-stocked with tools and resources, and is highly versatile.

Hospital and Diagnostic labs are the largest consumers of CRISPR-based diagnostics because of their existing infrastructure, high-throughput testing capacity, and growing utilization of cutting-edge molecular diagnostic methods for the detection of a myriad of diseases.

Pharmaceutical and biotechnology firms are increasingly using CRISPR-based diagnostics to develop drugs, conduct clinical trials, and ensure quality control.

North America dominates the CRISPR-based diagnostics market with the largest share. This is due to the high presence of prominent research establishments, prominent biotechnology and pharmaceutical organizations, and high amounts of government funding dedicated to research in diagnostics and genomics in North America.

CRISPR-Based Diagnostics Market- Segmentation Analysis:

The Global CRISPR-Based Diagnostics Market is segmented on the basis of Product, Technology, Application, End-use, and Region.

By Technology, the market is segmented into Cas9, Cas12, and Others. The Cas9 segment has the largest market share. This is largely due to Cas9 being the most widely studied and best-understood CRISPR-associated enzyme. Its strong and promiscuous DNA targeting ability has rendered it the workhorse for numerous diagnostic applications developed in the nascent phase of the market. The availability of a large collection of tools, reagents, and well-standardized protocols based on Cas9 has permitted extensive applications in research and diagnostics development. Furthermore, early achievement and establishment of Cas9-based diagnostic tests have reasserted its dominant role. The Cas12 component is the fastest-developing in the market. This is driven by the special strengths provided by Cas12 enzymes, including their capacity to digest their crRNA arrays and unique ssDNA trans-cleavage activity. This latter ability can offer higher sensitivity and easier assay design than the Cas9-based approaches. The continuous identification of novel Cas12 variants with better properties and the growing investigation of their potential applications in point-of-care diagnosis drive their rapid growth rate.

Based on Application, the market is segmented into Infectious Disease Diagnostics, Genetic Disorder Diagnostics, Cancer Diagnostics, and Others. Infectious disease diagnostics is the largest share of the market. This is fueled by the global demand for quick & precise identification of infectious pathogens. CRISPR-based diagnostics' ability to be rapidly repurposed for the detection of new and emerging infectious agents, as seen during recent pandemics, places them in a vital role in outbreak control and enhanced patient care. Their potential for point-of-care diagnostics and high sensitivity in detecting even minimal viral or bacterial loads are other factors that help them rule this segment. Cancer diagnostics is the most rapidly growing segment in the market. This is driven by the rising global cancer burden and the imperative for earlier and more accurate diagnostic tools to deliver better patient outcomes. With great sensitivity and specificity, CRISPR technologies provide great promise for detecting cancer-specific biomarkers, including circulating tumor DNA (ctDNA) in liquid biopsies. This could revolutionize early cancer detection, treatment response monitoring, and personalized cancer therapy.

CRISPR-Based Diagnostics Market- Geographical Insights

North America has the biggest market share. The region's strong research base, many major biotechnology and pharma companies actively contributing to CRISPR technology advancement, and the huge amount of government support for genomics and diagnostic research are the reasons behind its dominance. The strong healthcare infrastructure and the high adoption rate of sophisticated molecular diagnostic methods in North America are also additional factors. The leading nations in this regional market are the US, a center of advanced research and commercialization, and Canada, with increasing emphasis on biotechnology and healthcare innovation. The Asia-Pacific region is expected to be the most rapidly developing market for CRISPR-Based Diagnostics. This growth is driven by various factors, such as the growing incidence of infectious diseases and genetic disorders in the region's huge population, an increase in healthcare spending, an increase in awareness and acceptance of sophisticated diagnostic technologies, and higher investments in research and development in nations such as China, India, and South Korea.

CRISPR-Based Diagnostics Market- Competitive Landscape:

The CRISPR-based diagnostics market is featured by a rapidly evolving and highly competitive environment involving a mix of established life science companies, focused diagnostic developers, and cutting-edge startups. Major players are involved in ongoing research and development activities aimed at broadening the utility of CRISPR technology in diagnostics, improving assay sensitivity and specificity, and creating convenient and point-of-care-based solutions. Strategic collaborations, partnerships, and licensing are common as companies try to capitalize on complementary abilities and facilitate product development and commercialization. The continuous identification of new CRISPR-Cas systems and new assay formats further heightens the competitive pressure. Companies differentiate themselves based on product innovation, technological innovation, collaborations, and intelligent navigation of regulatory pathways. Developing aggressive, reliable, and scalable CRISPR-based diagnostic platforms for various applications like infectious diseases, cancer, and genetic disorders is a leitmotif in this new competitive environment.

Recent Developments:

October 2024: Mammoth Biosciences and Integrated DNA Technologies, Inc. (IDT) have partnered to co-develop and market new CRISPR-based diagnostic products. This collaboration will leverage Mammoth Biosciences' new CRISPR enzymes with IDT's nucleic acid synthesis and manufacturing capabilities to develop highly sensitive and scalable diagnostic tests for different applications.

January 2023: Thermo Fisher Scientific Inc. signed an agreement to license Caribou Biosciences' intellectual property related to using Caribou's Cas12a for developing novel diagnostic products. Under this agreement, Thermo Fisher can further enhance its molecular diagnostics portfolio by adding the distinctive strengths of Cas12a enzymes.

September 2023: ToolGen Inc. obtained a regulatory nod in South Korea for its CRISPR-based diagnostic kit, which is used to identify a particular genetic mutation related to a rare inherited condition. ToolGen reached a major milestone, proving the potential of CRISPR technology in identifying genetic diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific Inc.
Integrated DNA Technologies, Inc.
Molbio Diagnostics
Horizon Discovery
Synthego Corporation
Mammoth Biosciences
Sherlock Biosciences
Caribou Biosciences
CRISPRBits
ToolGen Inc.

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

Enzymes
Kits and Reagents
Software and Libraries

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

Cas9
Cas12
Others

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Infectious Disease Diagnostics
Genetic Disorder Diagnostics
Cancer Diagnostics
Others

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospitals and Clinics Diagnostic
Laboratories
Pharmaceutical and Biotechnology Companies
Others

GLOBAL CRISPR-BASED DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Crispr-Based Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Crispr-Based Diagnostics Market Snippet By Product
- 2.1.2. Crispr-Based Diagnostics Market Snippet By Technology
- 2.1.3. Crispr-Based Diagnostics Market Snippet By Application
- 2.1.4. Crispr-Based Diagnostics Market Snippet By End Use
- 2.1.5. Crispr-Based Diagnostics Market Snippet by Country
- 2.1.6. Crispr-Based Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Crispr-Based Diagnostics Key Market Trends

3.1. Crispr-Based Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Crispr-Based Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Crispr-Based Diagnostics Market Opportunities
3.4. Crispr-Based Diagnostics Market Future Trends

4. Crispr-Based Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Crispr-Based Diagnostics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Crispr-Based Diagnostics Market Landscape

6.1. Crispr-Based Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Crispr-Based Diagnostics Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Enzymes
- 7.1.3. Kits and Reagents
- 7.1.4. Software and Libraries

8. Crispr-Based Diagnostics Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 8.1.2. Cas9
- 8.1.3. Cas12
- 8.1.4. Others

9. Crispr-Based Diagnostics Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Infectious Disease Diagnostics
- 9.1.3. Genetic Disorder Diagnostics
- 9.1.4. Cancer Diagnostics
- 9.1.5. Others

10. Crispr-Based Diagnostics Market - By End Use

10.1. Overview
- 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
- 10.1.2. Hospitals and Clinics Diagnostic
- 10.1.3. Laboratories
- 10.1.4. Pharmaceutical and Biotechnology Companies
- 10.1.5. Others

11. Crispr-Based Diagnostics Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Crispr-Based Diagnostics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Crispr-Based Diagnostics Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Crispr-Based Diagnostics Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Crispr-Based Diagnostics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Crispr-Based Diagnostics Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Crispr-Based Diagnostics Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Thermo Fisher Scientific Inc.
- 12.2.2. Integrated DNA Technologies, Inc.
- 12.2.3. Molbio Diagnostics
- 12.2.4. Horizon Discovery
- 12.2.5. Synthego Corporation
- 12.2.6. Mammoth Biosciences
- 12.2.7. Sherlock Biosciences
- 12.2.8. Caribou Biosciences
- 12.2.9. CrisprBits
- 12.2.10. ToolGen Inc.

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us